Table 1.
Value | Local normal range | |
---|---|---|
Age-Median(range) | 9 year (7 m–13 year) | – |
Sex-Male/Female | 9/10 | – |
Clinical features-No. (%) | ||
Fever | 7 (37%) | – |
Cough | 9 (47%) | – |
Sore throat | 5 (26%) | – |
Rhinorrhea | 7 (37%) | – |
Pneumonia (by X-ray or CT) | 11 (58%) | – |
Laboratory findings-Median(range) | ||
WBCs × 109/L | 5.5 (3.2–16) | – |
29 d–3 y | 7.95 (6.4–8.7) | 6–12 |
> 3 y | 4.8 (3.2–16) | 4–10 |
Hemoglobin (g/dL) | 134 (4.7–168) | 110–160 |
Platelets × 109/L | 265 (128–404) | 100–400 |
Neutrophils × 109/L | 2.9 (1.15–11.2) | – |
29 d–3 y | 2.22 (1.67–2.90) | 2.4–4.8 |
> 3 y | 3.51 (1.15–11.2) | 2.0–7.0 |
Neutrophils (%) | 47.1 (25.3–75) | – |
29 d–3 y | 28.2 (25.2–43.4) | 30–40 |
> 3 y | 50.2 (27.3–75) | 50–70 |
Lymphocytes × 109/L | 2.34 (1.17–5.9) | – |
29 d–3 y | 5.05 (4.5–5.9) | 4.0–8.4 |
> 3 y | 2 (1.17–4) | 1.2–4.0 |
Lymphocytes (%) | 42 (17.5–69.8) | – |
29 d–3 y | 63.25 (48.5–69.8) | 50–70 |
> 3 y | 41 (17.5–66.9) | 30–40 |
Procalcitonin (ng/dL) | 0.04 (0.02–0.12) | < 0.05 |
C-reactive protein (mg/L) | 5.11 (0.5–35) | < 8 |
IL-6 (pg/mL) | 4.465 (0.91–24.77) | < 7 |
Erythrocyte sedimentation rate (mm/h) | 14 (4–39) | 0–26 |
Alanine transaminase (U/L) | 16.5 (6.9–100) | 7–50 |
Aspartate aminotransferase (U/L) | 28.9 (15.4–142) | 13–40 |
Urea (mmol/L) | 3.6 (1.97–5.7) | 2.8–7.6 |
Creatine kinase-MB (U/L) | 21.4 (12.3–51.9) | < 25 |
Lactate dehydrogenase (U/L) | 220 (156–383) | 110–430 |
Myohemoglobin (μg/L) | 9 (6–11) | 10–46 |
Total protein (g/L) | 74.3 (59–85.6) | 60–80 |
Albumin (g/L) | 44.9 (38.8–51.1) | 40–55 |
Globulin (g/L) | 28.6 (17.9–35.1) | 20–30 |
IgG (g/L) | 11.8 (9.9–14.5) | 3.5–14.26 |
IgA (g/L) | 1.4 (0.44–2.56) | 0.06–2.5 |
IgM (g/L) | 1.28 (0.76–2.35) | 0.36–2.16 |
Total-IgE (IU/ml) | 73.12 (7.91–1134.01) | < 100 |
D-dimer (mg/L) | 0.58 (0.33–1.02) | 0–0.5 |
COVID-19, Coronavirus Disease 2019; CT, computed tomography